ClinicalTrials.govpublic full text
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
gestational trophoblastic neoplasia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 369835
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.